France health minister: Limits on malaria drug

Image
AP Paris
Last Updated : May 23 2020 | 8:33 PM IST

France's health minister wants to limit use of a popular malaria drug as a coronavirus treatment after a new study found it ineffective and warned of increased health risks.

Olivier Veran tweeted Saturday that he asked France's public health council to draft new rules for prescribing hydroxychloroquine and other treatments within 48 hours.

He specifically cited a study of 100,000 patients worldwide, published Friday in the Lancet, saying hydroxychloroquine and related drug chloroquine were ineffective against the virus and were tied to a greater risk of death and heart rhythm problems.

Prominent French virologist Dr. Didier Raoult drew international attention including from U.S. President Donald Trump for his research early in the pandemic suggesting hydroxychloroquine reduced virus symptoms. Raoult's office didn't comment on the minister's move.

France included the drug in a trial of multiple treatments and allowed its use for hospitalized patients.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 23 2020 | 8:32 PM IST

Next Story